These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 28243980)
21. Enhancement of membrane B7-H3 costimulatory molecule but reduction of its soluble form in multiple sclerosis. Jiang J; Jiang J; Liu C; Zhang G; Gao L; Chen Y; Zhu R; Wang T; Wang F; Zhang X; Xue Q J Clin Immunol; 2013 Jan; 33(1):118-26. PubMed ID: 22996270 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma. Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443 [TBL] [Abstract][Full Text] [Related]
23. [Expression of B7-H3 costimulatory molecule in peripheral blood of myasthenia gravis patients]. Jiang JA; Xue Q; Liu CP; Gao L; Zhang GB; Chen YJ; Zhang XG Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):856-9. PubMed ID: 22863596 [TBL] [Abstract][Full Text] [Related]
24. Increased concentrations of soluble B7-H3 and interleukin 36 in bronchoalveolar lavage fluid of Children with Mycoplasma pneumoniae pneumonia. Chen Z; Zhao X; Zhang X; Zhang G; Sun H; Jiang W; Wang Y; Zhu C; Ji W; Yan Y BMC Infect Dis; 2016 May; 16():212. PubMed ID: 27188891 [TBL] [Abstract][Full Text] [Related]
25. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II. Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134 [TBL] [Abstract][Full Text] [Related]
26. Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma. Reichl P; Fang M; Starlinger P; Staufer K; Nenutil R; Muller P; Greplova K; Valik D; Dooley S; Brostjan C; Gruenberger T; Shen J; Man K; Trauner M; Yu J; Gao CF; Mikulits W Int J Cancer; 2015 Jul; 137(2):385-394. PubMed ID: 25529751 [TBL] [Abstract][Full Text] [Related]
27. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model. Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667 [TBL] [Abstract][Full Text] [Related]
28. Soluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-κB pathway. Xie C; Liu D; Chen Q; Yang C; Wang B; Wu H Sci Rep; 2016 Jun; 6():27528. PubMed ID: 27273624 [TBL] [Abstract][Full Text] [Related]
29. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection. Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288 [TBL] [Abstract][Full Text] [Related]
30. Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma. Sadeghi M; Lahdou I; Oweira H; Daniel V; Terness P; Schmidt J; Weiss KH; Longerich T; Schemmer P; Opelz G; Mehrabi A Br J Cancer; 2015 Sep; 113(5):756-62. PubMed ID: 26270232 [TBL] [Abstract][Full Text] [Related]
31. Liver Cancer-Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma. Lu F; Shah PA; Rao A; Gifford-Hollingsworth C; Chen A; Trey G; Soryal M; Talat A; Aslam A; Nasir B; Choudhry S; Ishtiaq R; Sanoff H; Conteh LF; Noonan A; Hu KQ; Schmidt C; Fu M; Civan J; Xiao G; Lau DT; Lu X Clin Transl Gastroenterol; 2020 Dec; 11(12):e00271. PubMed ID: 33512798 [TBL] [Abstract][Full Text] [Related]
32. Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma. Masuda A; Arai K; Nishihara D; Mizuno T; Yuki H; Kambara T; Betsunoh H; Abe H; Yashi M; Fukabori Y; Yoshida K; Kamai T Biomed Res Int; 2014; 2014():396064. PubMed ID: 25089268 [TBL] [Abstract][Full Text] [Related]
33. Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase. Yang JD; Dai J; Singal AG; Gopal P; Addissie BD; Nguyen MH; Befeler AS; Reddy KR; Schwartz M; Harnois DM; Yamada H; Gores GJ; Feng Z; Marrero JA; Roberts LR Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1085-1092. PubMed ID: 28258053 [No Abstract] [Full Text] [Related]
34. Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer. Shi H; Ji M; Wu J; Zhou Q; Li X; Li Z; Zheng X; Xu B; Zhao W; Wu C; Jiang J World J Surg Oncol; 2014 Jun; 12():188. PubMed ID: 24947047 [TBL] [Abstract][Full Text] [Related]
35. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients. Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708 [TBL] [Abstract][Full Text] [Related]
36. Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum. Zhang G; Hou J; Shi J; Yu G; Lu B; Zhang X Immunology; 2008 Apr; 123(4):538-46. PubMed ID: 18194267 [TBL] [Abstract][Full Text] [Related]
37. Serum peroxiredoxin3 is a useful biomarker for early diagnosis and assessemnt of prognosis of hepatocellular carcinoma in Chinese patients. Shi L; Wu LL; Yang JR; Chen XF; Zhang Y; Chen ZQ; Liu CL; Chi SY; Zheng JY; Huang HX; Yu FJ; Lin XY Asian Pac J Cancer Prev; 2014; 15(7):2979-86. PubMed ID: 24815434 [TBL] [Abstract][Full Text] [Related]
38. Diagnosis value of serum soluble B7-H4 expression in non-small cell lung cancer. Xu CH; Wang W; Wang YC; Lin Y; Zhang XW Clin Respir J; 2018 Jan; 12(1):134-139. PubMed ID: 27216449 [TBL] [Abstract][Full Text] [Related]
39. [Expression and Clinical Significance of Soluble B7-H3 in Patient with Secondary Hemophagocytic Lymphohistiocytosis]. Lyu X; Wang Y; Wang LL; Yin GL; Liu LL; Duan LM; Tian T; Xu J; Qiu HX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):1006-1011. PubMed ID: 32552973 [TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA. Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]